Khadija Benlhassan serves as Executive at Immunoclin Corp, where they oversee executive responsibilities. Since joining the company, Khadija Benlhassan has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 10, 2015 involved receiving (via award) 2,000,000 shares valued at $10.0M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 10, 2015 | IMCL | $10.0M | Award | 2,000,000 | $5.00 | Discretionary |
Khadija Benlhassan currently holds 4,000,000 shares of Immunoclin Corp (IMCL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Khadija Benlhassan has been a net neutral trader of IMCL stock. They have purchased $0 and sold $0 worth of shares.
Khadija Benlhassan's most recent insider trade was on Jun 10, 2015, when they sold 2,000,000 shares at $5.00 per share.
Get notified when new Form 4 filings are submitted